SCHEMBL24971013

SCHEMBL24971013

Clc1cc2ncccc2nc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
NR4A2 P43354 2/20 0.47
ALDH1A1 P00352 6/20 0.46
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
DOT1L Q8TEK3 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.41
CCR1 P32246 1/20 0.40
CCR8 P51685 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 4/20 0.39
PKM P14618 1/20 0.39
CYP3A4 P08684 1/20 0.39
CASP1 P29466 2/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.38
CASP7 P55210 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30903381 1.00 CASP6 (0.52) CASP6TDP1NR4A2ALDH1A1NPC1
SCHEMBL28065796 0.80 CASP6 (0.49) CASP6TDP1NR4A2ALDH1A1NPC1
SCHEMBL28107525 0.80 TDP1 (0.46) CASP6TDP1NR4A2ALDH1A1NPC1
SCHEMBL29987120 0.80 CASP6 (0.58) CASP6NR4A2ALDH1A1NPC1RAB9A
SCHEMBL28065792 0.80 CASP6 (0.53) CASP6TDP1NR4A2ALDH1A1NPC1
SCHEMBL28065783 0.80 TDP1 (0.46) CASP6TDP1NR4A2ALDH1A1NPC1
Quinoxaline SCHEMBL28427327 0.76 KMT2A (0.50) CASP6TDP1NR4A2ALDH1A1NPC1
SCHEMBL1993651 0.76 TOP1 (0.50) TDP1NR4A2ALDH1A1NPC1RAB9A
SCHEMBL27963113 0.76 NPSR1 (0.43) CASP6TDP1NR4A2ALDH1A1KDM4E
SCHEMBL27864539 0.74 SMN1; SMN2 (0.56) TDP1ALDH1A1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327354-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS INSTITUT PASTEUR DE LILLE (FR) 2024-10-03 US disclosed
EP-4373808-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS Institut national de la santé et de la recherche médicale (INSERM) (FR) 2024-05-29 EP disclosed
CN-118076585-A Gram negative bacteria efflux pump inhibitors 国家医疗保健研究所 2024-05-24 CN disclosed
WO-2023002011-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-01-26 WO disclosed
WO-2023002011-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327354-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS ABCB11, ABCB1, ATP4B CASP6 1873/4885TDP1 4206/4885NR4A2 3571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.